🇺🇸 FDA
Pipeline program

SUMATRIPTAN , GLYCERYL TRINITRATE , RIMEGEPANT

MAMBO-II

Approved small_molecule active

Quick answer

SUMATRIPTAN , GLYCERYL TRINITRATE , RIMEGEPANT for Migraine is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
Migraine
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials